Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology
Imagin Medical Inc. successfully weathered the 2020 pandemic-induced economic challenges and transitioned its surgical visualization product, the i/Blue Imaging System(TM) from the development stage to manufacturing and has after Imagin’s next stage will be supported by a $3 million convertible note, with the final funding tranche expected to close this quarter The i/Blue Imaging System combines the advantages of blue light with advanced optic and light sensors to address the limitations of both white and blue light imaging to help surgeons better visualize and remove cancerous cells. The system uses a contrast agent to highlight the cancer and projects both…